IBRX

ImmunityBio, Inc.
8.74 -0.79% 2026-10-29

Last 90d 1 insider sale · 2 congress buys

52-week range
1.95 12.43
1-month-7.4%
3-month+21.9%
1-year+238.8%
3-year+385.6%
5-year+3.4%
vs 50-day+0.5%
vs 200-day+11.0%
Volatility107%
Beta1.65
$ vol/day$142M
ATH45.42
From ATH-80.8%
Next report2026-11-03
WhoEntryMove What they saidWhen
TRACKER - Lisa McClain · Congress long 9.95 -12.2% Lisa McClain's trade date was 28 September 2026 — a disclosed purchase of $1,001–$15,000. But a Periodic Transaction… Tue, 13 Oct
2026AprJulOct

bought sold · bigger dot, bigger trade · follows the chart’s range

WhenPeople SizeValuePrice
23d sched 2 $1,119,848 9.98
4mo sched 2 $2,686,007 9.08
4mo sched 1 $871,216 8.93
4mo sched 1 $197,000 8.26
5mo sched 1 $165,377 7.04
8mo sched 1 $900,750 9.48
8mo sched 2 $2,033,750 11.11
9mo sched 2 $1,532,114 6.40
3.4y buy 3 $289,093 2.84
5.1y buy 1 $17,005 9.21
5.2y sell 1 $249,546 11.02
5.2y sell 1 $460,582 9.23
5.4y sell 1 $2,017,755 16.06
2026AprJulOct

bought sold · bigger dot, bigger trade · follows the chart’s range

LMLisa McClain 2B 29d DGDaniel Goldman 1S 3.7y

2 members · 2 buys / 1 sells · $3K–$45K disclosed · latest filing Oct 12, 2026 · full tracker ›

WhenMemberSize AmountPrice then
29d buy LM Lisa McClain $1K–$15K 9.44
1mo buy LM Lisa McClain $1K–$15K 8.52
3.7y sell DG Daniel Goldman $1K–$15K 1.76

Next report 2026-11-03 (Tuesday, before open, in 5 days) · EPS estimate -0.05. It has finished the next session higher 27% of the time, average move 10.2%.

Day-after move, last 12 reports, oldest left.

ReportedEst.Actual SurpriseGapDay 1Day 5
2026-08-04 miss -0.08 -0.22 -175.0% -5.5% -2.8% +6.3%
2026-05-07 miss -0.07 -0.08 -20.0% -6.7% -7.4% -2.7%
2026-02-23 beat -0.10 -0.06 +37.9% +14.4% +13.0% +20.0%
2025-11-04 beat -0.10 -0.07 +30.0% +5.3% +3.4% -1.0%
2025-08-05 -0.10 -0.10 — -0.4% +0.0% +2.5%
2025-05-12 miss -0.14 -0.15 -7.1% +8.9% +14.0% +35.3%
2025-03-03 beat -0.13 -0.08 +38.5% -2.7% -13.4% -11.6%
2024-11-12 beat -0.18 -0.12 +33.3% -1.7% -9.2% -1.8%
2024-08-12 miss -0.15 -0.20 -33.3% -1.1% -2.6% -11.9%
2024-05-09 miss -0.16 -0.20 -25.0% -2.2% +0.7% -5.1%
2024-03-19 miss -0.18 -0.38 -111.1% +1.3% +10.3% +0.6%
2023-11-09 miss -0.18 -0.19 -5.6% -2.3% -17.1% +19.2%
2023-08-08 miss -0.23 -0.32 -36.2% -0.5% -10.2% +5.4%
2023-05-11 -0.27 -0.27 — -55.7% -55.1% -54.8%
2023-03-01 miss -0.16 -0.27 -63.6% +1.3% -10.6% -33.3%
2022-11-09 miss -0.21 -0.28 -30.2% -2.3% -10.7% +16.6%
2022-08-08 -0.24 -0.24 — -1.1% -2.9% +1.8%
2022-05-10 miss -0.22 -0.26 -18.2% +0.0% -22.3% +9.0%
2022-03-01 miss -0.21 -0.23 -9.5% +0.3% -1.4% +3.4%
2021-11-12 miss -0.20 -0.22 -10.0% +1.7% -7.5% -21.1%
2021-08-12 miss -0.12 -0.23 -91.7% -0.8% -1.3% -12.3%
2021-05-14 beat -0.41 -0.21 +48.8% +4.6% +9.6% +3.8%
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.3%
Next 1 week
+0.2%
Next 1 month
+4.0%
Seasonality
Mildly positive window
Next 30 days (to Nov 28): +0.7% median, 50% of the last 10 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 67
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.13%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.65 +4.3% · Seasonal tilt (10y) -0.3%
$142M/day volume 107% volatility +239% 1-year -81% from ATH
52-week range · 65% of the way up · -30% from the high
$1.95$12.43

Not investment advice.